In polycystic kidney disease, targeting ciliary dysfunction through cAMP modulation, growth factor inhibition, microRNA-17 inhibition, and mTOR inhibition has demonstrated therapeutic potential [156]. Here, MTOR is linked to polycystic kidney disease.